PMID: 42291047

Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE - primary prevention study.

Smolderen Kim G, Mena-Hurtado Carlos, Divino Victoria, Zhao Zhenxiang, Chen Yan, Boland Joanna, Chao Ariel, Song Jinlin, Smolarz B Gabriel, Knop Filip K

American journal of preventive cardiology · 2026

Vol. 27, pp. 101521

This entry links to third-party literature. For research use only.